Value of Penile Elastography in Diagnosis of Patients With Erectile Dysfunction and Non-responders to Intra-corporal Injection

NCT04864288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-04-28

No results posted yet for this study

Summary

Penile erection is a neurovascular response that induces penile arterial dilatation, increased blood flow, and cavernous smooth muscles (CSM) relaxation; the enlarging corpora cavernosa compress the subtunical veins, against a rigid tunica albuginea, and entrap blood within the penis. Impaired CSM function can result in corporo veno-occlusive dysfunction (CVOD) and erectile dysfunction. Nevertheless, diagnostic tests, which can evaluate the status of CSM, are not clinically applicable. Penile elastography is a new promising tool that can assess the stiffness of the corpora cavernosa. Accordingly penile elastography can assess the status of the cavernous tissue and can distinguish patient with corporal fibrosis.

Conditions

  • To Investigate the Value of Penile Elastography in the Diagnosis of Fibrosis of CC

Interventions

DEVICE

Shear Wave Elastography

is a quantitative method in which the probe generates acoustic impulses through the tissue to create molecular vibration. These vibrations create shear waves so that elasticity might be calculated, because it is proportional to the speed of the waves

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER
  • Ramzy Raafat Mohamed Mohamed Elnabarawy, MD, MSc, MRCS

    lead OTHER

Principal Investigators

  • Ramzy RM Elnabarawy · Kasr Alainy

Eligibility

Min Age
21 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-28
Primary Completion
2020-01-28
Completion
2020-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04864288 on ClinicalTrials.gov